These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 475697)
21. Toxic epidermal necrolysis associated with sulfonamides. Margolis DJ; Bondi EE Int J Dermatol; 1990 Mar; 29(2):153. PubMed ID: 2323873 [No Abstract] [Full Text] [Related]
22. [Role of various drugs in the activation of systemic lupus erythematosus]. Alarcón Segovia D Rev Invest Clin; 1966; 18(3):445-66. PubMed ID: 4867683 [No Abstract] [Full Text] [Related]
33. THE COLLAGENOSES: TRANSITIONAL FORMS OF LUPUS ERYTHEMATOSUS, DERMATOMYOSITIS, AND SCLERODERMA. KIERLAND RR Mayo Clin Proc; 1964 Jan; 39():53-9. PubMed ID: 14105415 [No Abstract] [Full Text] [Related]
34. [Systemic lupus erythematosus (SLE). II. New insights into its etiology]. Feltkamp TE Ned Tijdschr Geneeskd; 1974 Feb; 118(5):171-5. PubMed ID: 4825320 [No Abstract] [Full Text] [Related]
35. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Pelle MT; Callen JP Arch Dermatol; 2002 Sep; 138(9):1231-3; discussion 1233. PubMed ID: 12224986 [TBL] [Abstract][Full Text] [Related]
36. [Lupoid syndrome]. Mysliaeva AV Ter Arkh; 1975; 47(12):111-2. PubMed ID: 1224313 [No Abstract] [Full Text] [Related]